← Eichor
Study identifier: NCT07196033 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Condition: Stage IIIA Cervical Cancer FIGO 2018 · Stage IIIB Cervical Cancer FIGO 2018 · Stage IVA Cervical Cancer FIGO 2018  ·  Sponsor: Tata Memorial Hospital

PhaseN/A
Planned participants1000
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

Gynecological cancer poses as significant public health issue, especially in Asian countries, where it is a leading cause of cancer-related deaths among women. Cervical cancer accounts for around 311,000 deaths annually, with over 85% occurring in low- and middle-income nations, primarily in Asia. Factors contributing to this burden include limited access to preventive care, inadequate screening, high rates of human papillomavirus infection, and cultural barriers that delay medical attention. For patients with advanced cervical cancer, the standard treatment involves external beam radiation therapy along with chemotherapy followed by internal radiation, known as Brachytherapy. This technique uses unique set of devices placed internally at the tumor sitegiving localized radiation to the residual tumor tissue. While advanced brachytherapy techniques have been developed and practiced in Europe and American countries yielding excellent clinical outcomes, there is insufficient data on the use and results of such advanced brachytherapy techniques in Asian populations, leading to a lack of standardized practices. To address these issues, the Asian Gynecological Brachytherapy Registry (ABGR) has been established as a collaborative platform for data collection and analysis on the use of Brachytherapy techniques. This registry aims to consolidate information from various healthcare settings across Asia, enhancing understanding of cervical cancer's epidemiology, evaluating treatment e…

This description comes directly from the study's public registry record.

Talk to the study team

Dr. Supriya Chopra  ·  9930958309  ·  supriyasastri@gmail.com

Always discuss trial participation with your own doctor first.

Locations (5)

Tata Memorial CenterMumbai, Maharashtra, IndiaRecruiting
Gunma UniversityMaebashi, Japan, JapanNot Yet Recruiting
Juntendo UniversityTokyo, Japan, JapanNot Yet Recruiting
Mahidol UniversityBangkok, Thailand, ThailandNot Yet Recruiting
Chiang Mai UniversityChiang Mai, Thailand, ThailandNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07196033